Citigroup’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-122,752
| Closed | -$3.31M | – | 5161 |
|
|
2022
Q4 | $3.31M | Sell |
122,752
-26,767
| -18% | -$722K | ﹤0.01% | 1252 |
|
|
2022
Q3 | $2.69M | Buy |
149,519
+41,388
| +38% | +$743K | ﹤0.01% | 1424 |
|
|
2022
Q2 | $1.34M | Buy |
108,131
+61,884
| +134% | +$769K | ﹤0.01% | 1853 |
|
|
2022
Q1 | $616K | Sell |
46,247
-143,022
| -76% | -$1.91M | ﹤0.01% | 2714 |
|
|
2021
Q4 | $2.95M | Buy |
189,269
+87,812
| +87% | +$1.37M | ﹤0.01% | 1676 |
|
|
2021
Q3 | $2.28M | Sell |
101,457
-75,034
| -43% | -$1.68M | ﹤0.01% | 1816 |
|
|
2021
Q2 | $4.02M | Buy |
176,491
+174,871
| +10,795% | +$3.98M | ﹤0.01% | 1597 |
|
|
2021
Q1 | $33K | Buy |
1,620
+587
| +57% | +$12K | ﹤0.01% | 4293 |
|
|
2020
Q4 | $29K | Sell |
1,033
-2
| -0.2% | -$56 | ﹤0.01% | 4434 |
|
|
2020
Q3 | $15K | Sell |
1,035
-5,909
| -85% | -$85.6K | ﹤0.01% | 4122 |
|
|
2020
Q2 | $143K | Buy |
6,944
+6,817
| +5,368% | +$140K | ﹤0.01% | 3256 |
|
|
2020
Q1 | $1K | Sell |
127
-8
| -6% | -$63 | ﹤0.01% | 5029 |
|
|
2019
Q4 | $2K | Buy |
+135
| New | +$2K | ﹤0.01% | 5009 |
|
|
2019
Q1 | – | Sell |
-66
| Closed | -$1K | – | 5195 |
|
|
2018
Q4 | $1K | Buy |
66
+51
| +340% | +$773 | ﹤0.01% | 4976 |
|
|
2018
Q3 | $0 | Buy |
+15
| New | – | ﹤0.01% | 5173 |
|
|
2018
Q1 | – | Sell |
-41
| Closed | -$1K | – | 5058 |
|
|
2017
Q4 | $1K | Hold |
41
| – | – | ﹤0.01% | 4916 |
|
|
2017
Q3 | $1K | Sell |
41
-6
| -13% | -$146 | ﹤0.01% | 4639 |
|
|
2017
Q2 | $1K | Sell |
47
-64
| -58% | -$1.36K | ﹤0.01% | 4787 |
|
|
2017
Q1 | $1K | Sell |
111
-10,590
| -99% | -$95.4K | ﹤0.01% | 4757 |
|
|
2016
Q4 | $133K | Buy |
+10,701
| New | +$133K | ﹤0.01% | 3791 |
|